Reata Pharmaceuticals Inc...

NASDAQ: RETA · Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 8:00 PM

Reata Pharmaceuticals Statistics

Share Statistics

Reata Pharmaceuticals has 38.1M shares outstanding. The number of shares has increased by 0% in one year.

38.1M
0%
0%
n/a
n/a
680
0.07%

Short Selling Information

The latest short interest is 2.39M, so 6.28% of the outstanding shares have been sold short.

2.39M
6.28%
8.14%
3.09

Valuation Ratios

The PE ratio is -4.42 and the forward PE ratio is null. Reata Pharmaceuticals's PEG ratio is -0.91.

-4.42
n/a
622.68
n/a
-21
-6.65
-0.91
Financial Ratio History

Enterprise Valuation

Reata Pharmaceuticals has an Enterprise Value (EV) of 1.46B.

657.49
-5.42
-7.13
-7.02

Financial Position

The company has a current ratio of 6.75, with a Debt / Equity ratio of -1.82.

6.75
6.75
-1.82
-0.44
-0.58
-6.47

Financial Efficiency

Return on Equity is 474.77% and Return on Invested Capital is -502.4%.

474.77%
-60.62%
-502.4%
$6,903.43
$-971,654.21
321
0
n/a

Taxes

-25K
0.01%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.42, so Reata Pharmaceuticals's price volatility has been higher than the market average.

1.42
n/a
159.77
95.71
84.69
954,093

Income Statement

In the last 12 months, Reata Pharmaceuticals had revenue of 2.22M and earned -311.9M in profits. Earnings per share was -8.59.

2.22M
2.22M
-270.15M
-311.9M
-269.02M
-270.15M
-8.59
Full Income Statement

Balance Sheet

The company has 42.31M in cash and 119.46M in debt, giving a net cash position of -77.15M.

42.31M
119.46M
-77.15M
-1.57B
502.59M
276.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -204.27M and capital expenditures -3.27M, giving a free cash flow of -207.54M.

-204.27M
-3.27M
-207.54M
-5.71
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -12191.11% and -14074.95%.

100%
-12191.11%
-14076.08%
-14074.95%
-12140.12%
-12191.11%
-9365.39%

Dividends & Yields

RETA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-22.6%
-15.04%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for RETA.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

5.36
2